English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

EU approves the active ingredient of Stockton's Timorex Gold®qrcode

Apr. 29, 2014

Favorites Print
Forward
Apr. 29, 2014

STK
Israel  Israel
Follow

EU approves the active ingredient of Stockton's Timorex Gold®

Timorex Gold®
Category:Biopesticide
Company:STK
Israel’s Stockton Group, which specializes in innovative plant extract based crop protection products, announces that the active ingredient in the company's flagship product Timorex Gold® - received final EU approval to be included in Annex1 (certificate relating to the level of the active ingredient in the product).

Stockton is now undergoing the second phase, called Annex 3, relating to the final product. This process is expected to be completed in 2017. Stockton expects to receive 10 years’ protection commencing once the product is finally approved.

Ziv Tirosh, CEO of the Stockton Group, stated: “EU approval is an important milestone for TimorexGold®.This is a significant confirmation of our product’s platform, paving the way for the flow of our new and innovative products and for sustainable crop protection. Very few companies attempt to obtain these EU certifications because of the high hurdle involved, and the long, very complex and expensive process. More than that, even fewer companies are successful because of the knowledge and level required. European market certification is extremely important for our product, and we anticipate a great commercial future for our product in this significant market."

TimorexGold®is a plant extract-based, bio-fungicide, approved for use in organic and conventional agriculture in over 25 countries, including most countries of Central and South America, Australia, Canada, the Philippines and Serbia.

TimorexGold®is a broad-range bio-fungicide, active on a variety of diseases in many crops such as bananas, grapes, tomatoes, cucumbers, etc.


Source: STK Group

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox